The period from initiation of corticosteroid therapy to relapse of AIP.

<p>Kaplan–Meier plots of the cumulative relapse rate of type 1 autoimmune pancreatitis grouped for various parameters. Patients who had an elevated serum IgG4 level of 550 mg/dL or more (<i>p</i> = 0.127) tended to experience early relapse. Serum IgG level of 1800 mg/dLor more (<i>p</i> = 0.724) and maintenance dose of 5 mg/day or more (<i>p</i> = 0.452) were not associated with early relapse. Grouped for administration period of CST, AIP patients who ceased CST within 2 or 3 years experienced significantly earlier relapse than those who had the continuance of CST (<i>p</i> = 0.050 or <i>p</i> = 0.020).</p

Clinical characteristics of the patients with or without relapse.

<p>Clinical characteristics of the patients with or without relapse.</p

The clinical course of diabetes mellitus grouped for the type of onset.

<p>The clinical course of diabetes mellitus grouped for the type of onset.</p

Clinical characteristics of the patients with type 1 autoimmune pancreatitis.

<p>Clinical characteristics of the patients with type 1 autoimmune pancreatitis.</p

The association between the presence of diabetes mellitus and the clinical characteristics of the type 1 autoimmune pancreatitis.

<p>The association between the presence of diabetes mellitus and the clinical characteristics of the type 1 autoimmune pancreatitis.</p